Related Experiment Video
Updated: May 21, 2026
06:36
Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
The vanadyl ribonucleoside complex inhibits ribosomal subunit formation in Staphylococcus aureus
Ashley D Frazier1, W Scott Champney
1Department of Biochemistry and Molecular Biology, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA.
The Journal of Antimicrobial Chemotherapy
|May 31, 2012
Summary
The vanadyl ribonucleoside complex (VRC) specifically inhibits bacterial ribosomal subunit formation in Staphylococcus aureus by targeting RNases, reducing cell viability and rRNA. This discovery offers a new strategy against antibiotic resistance.
Area of Science:
- Microbiology
- Molecular Biology
- Drug Discovery
Background:
- Antibiotic resistance necessitates novel therapeutic targets.
- Bacterial ribosomes are key targets for many antibiotics, inhibiting translation.
- Ribosome subunit formation is also a crucial target, involving rRNA processing by RNases.
Purpose of the Study:
- To investigate the vanadyl ribonucleoside complex (VRC) as an inhibitor of RNases involved in ribosomal subunit formation in Staphylococcus aureus.
- To determine if VRC affects protein synthesis or ribosomal subunit assembly.
Main Methods:
- Assessed VRC's effect on S. aureus viability using colony counting.
- Measured protein synthesis via isotopic methionine incorporation.
- Quantified ribosome synthesis using radiolabelled uridine incorporation and sucrose gradients.
- Analyzed subunit synthesis rates with pulse-chase radiolabelling and RNA turnover with a gel-on-a-chip assay.
Main Results:
- VRC significantly reduced the rates and amounts of both ribosomal subunits.
- Ribosomal RNA degradation and reduced cell viability were observed in VRC-treated cells.
- VRC enhanced the inhibitory effects of macrolide and aminoglycoside antibiotics on ribosome formation.
Conclusions:
- VRC specifically impairs bacterial ribosomal subunit synthesis in Staphylococcus aureus.
- Reduced subunit rates and amounts, alongside increased rRNA turnover, lead to decreased cell viability.
- VRC presents a potential new avenue for combating antibiotic resistance by targeting ribosome biogenesis.
More Related Videos
Related Concept Videos
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:23Types of RNA
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...